Zabrus SPRL
Zabrus reported total assets of 119,641 € at the end of the 2025 financial year (annual accounts filed with the NBB on 13 May 2026).
The score of Zabrus shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +18 % Total assets -15 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Zabrus's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 21,415 € | ||||
| Equity | 80,859 € | ||||
| Cash | 53,991 € | ||||
| EBITDA | 29,094 € | ||||
| Total assets | 119,641 € |
Filed annual accounts
- Year ended 30 Sep 2025filed on 13 May 2026
- Year ended 30 Sep 2024filed on 15 May 2025
- Year ended 30 Sep 2023filed on 25 Apr 2024
- Year ended 30 Sep 2022filed on 18 Apr 2023
- Year ended 30 Sep 2021filed on 28 Apr 2022
Zabrus's financial analysis
- Solvency67.6%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Zabrus
Zabrus's publications in the Belgian Gazette
No Belgian Gazette publication known for this company.
Company number, VAT number and registered office
- Company number (CBE)
- 0444.250.892
- VAT number
- BE0444250892
- Peppol
- Registered · 0208:0444250892 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 27 May 1991
- Registered office
- 9830 Sint-Martens-Latem
- Latest accounts
- 2025 · filed on 13 May 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Zabrus (SPRL) has been based in Sint-Martens-Latem since 1991, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 21,415 € and equity of 80,859 €; its revenue is not published. Its solvency stands at 67.6%, above the median of its sector (46.0%).
Companies similar to Zabrus
Companies in the same business, of comparable size and area, outside its group.
- Noreva BE Wholesale of pharmaceutical and medical goods Ghent · balance sheet 99,431 €
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- NBS Scientific Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 152,659 €
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Biocon Biologics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.09m
- Wimeq Wholesale of pharmaceutical and medical goods Heusden-Zolder · balance sheet 48,978 €
- MiniMed Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet 8,076 €
Frequently asked questions about Zabrus
What is the revenue of Zabrus?
Zabrus files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Zabrus?
In Belgium, the VAT number is the company number prefixed with BE: BE0444250892 for Zabrus, if the company is VAT-registered. Its company number (CBE) is 0444.250.892.
Where is the registered office of Zabrus?
According to the CBE register, the registered office of Zabrus is in 9830 Sint-Martens-Latem.
What is the equity of Zabrus?
At the close of the 2025 financial year, the equity of Zabrus amounts to 80,859 €, a solvency of 67.6% of total assets.
Who manages Zabrus?
The register lists 1 active mandates at Zabrus. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Zabrus
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →